Edition:
International

Matthias Blamont

Analysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow

Aug 05 2021

PARIS Pharmaceutical company Sanofi remains under pressure to launch new drugs and overcome setbacks in the COVID-19 vaccine race, despite a $3.2 billion deal to tighten its grip on promising mRNA technology.

Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal

Aug 03 2021

PARIS Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA vaccine technology beyond the COVID-19 pandemic, confirming a Reuters exclusive report.

Exclusive-Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources

Aug 03 2021

PARIS Sanofi has offered to buy U.S. biotech company Translate Bio, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race.

Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal

Aug 03 2021

PARIS Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA vaccine technology beyond the COVID-19 pandemic, confirming a Reuters exclusive report.

EXCLUSIVE-Sanofi offers to buy U.S. mRNA partner Translate Bio -sources

Aug 02 2021

PARIS, Aug 2 Sanofi has offered to buy U.S. biotech company Translate Bio, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race.

Sanofi raises profit forecast after second quarter beat

Jul 29 2021

PARIS (Reuters) -Sanofi raised its 2021 profit forecast on Thursday after its vaccines and star eczema treatment Dupixent helped it beat second-quarter results expectations.

UPDATE 1-No health pass, no cinema or museum: France tightens COVID-19 rules

Jul 21 2021

* Introduction of health pass triggers nationwide protests (Updates with PM interview)

After vaccination burnout, Delta variant spurs countries to speed up shots

Jul 13 2021

The daily pace of COVID vaccinations has increased in about a dozen countries due to the arrival of the more contagious Delta variant and governments expanding their vaccination drives, a data analysis by Reuters found.

From game-changer to back-up - J&J's COVID vaccine struggles in Europe

Jun 23 2021

BRUSSELS (Reuters) -At the height of Europe's vaccine supply crisis in March, Johnson & Johnson's (J&J) single-dose COVID-19 vaccine was touted as a game-changer. But two months into its rollout, the shot has the lowest uptake of all four approved vaccines.

World News